Dietary iron elevates LDL-cholesterol and decreases plasma antioxidant levels: Influence of antioxidants

被引:0
|
作者
Pool, GF [1 ]
van Jaarsveld, H [1 ]
机构
[1] Univ Orange Free State, Univ Hosp, Dept Chem Pathol, ZA-9300 Bloemfontein, South Africa
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
High body iron and LDL-cholesterol concentrations, and antioxidant deficiency, are regarded as risk factors for ischemic heart disease. Iron is well known for causing oxidative damage and antioxidants for their beneficial effects on radical scavenging. It is, however, unknown whether or not dietary iron causes depletion of plasma antioxidants; causes lipid peroxidation; alters HDL- and LDL-cholesterol, and triglyceride concentrations. Rats received diets differing only in iron concentration - 15 mg/Kg, 35 mg/Kg, 150 mg/Kg or 300 mg/Kg diet. The second group of rats received antioxidants (atocopherol and beta-carotene) in their drinking water. Increasing dietary iron increased plasma lipid hydroperoxide and LDL-cholesterol concentrations, but did not affect HDL-cholesterol or triglyceride concentrations. It decreased antioxidants, alpha-tocopherol and retinol. Antioxidant supplementation inhibited the above changes.
引用
收藏
页码:139 / 150
页数:12
相关论文
共 50 条
  • [1] REGULATION OF PLASMA LDL-CHOLESTEROL LEVELS BY DIETARY-CHOLESTEROL AND FATTY-ACIDS
    SPADY, DK
    WOOLLETT, LA
    DIETSCHY, JM
    [J]. ANNUAL REVIEW OF NUTRITION, 1993, 13 : 355 - 381
  • [2] LDL-CHOLESTEROL IN RAT PLASMA IS DECREASED BY DIETARY LEGUMES
    MURILLO, E
    DEANGELIS, RC
    [J]. BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1985, 18 (5-6) : A716 - A716
  • [3] Myeloid cells regulate plasma LDL-cholesterol levels
    Bazioti, Venetia
    La Rose, Anouk M.
    Westerterp, Marit
    [J]. CURRENT OPINION IN LIPIDOLOGY, 2018, 29 (03) : 233 - 239
  • [4] Baseline levels of LDL-cholesterol and lipoprotein(A) and the Ava II polymorphism of the LDL receptor gene influence the response of LDL-cholesterol to pravastatin treatment
    Lahoz, M
    Pena, R
    Mostaza, JM
    Laguna, F
    Garcia-Iglesias, MF
    Taboada, K
    Pinto, X
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 21 - 21
  • [5] ACTIVATION OF THE NUCLEAR RECEPTOR PXR DECREASES PLASMA LDL-CHOLESTEROL LEVELS AND INDUCES HEPATIC STEATOSIS IN LDL RECEPTOR KNOCKOUT MICE
    Hoekstra, M.
    Lammers, B.
    Out, R.
    Li, Z.
    van Eck, M.
    van Berkel, T.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [6] Activation of the Nuclear Receptor PXR Decreases Plasma LDL-Cholesterol Levels and Induces Hepatic Steatosis in LDL Receptor Knockout Mice
    Hoekstra, Menno
    Lammers, Bart
    Out, Ruud
    Li, Zhaosha
    Van Eck, Miranda
    Van Berkel, Theo J. C.
    [J]. MOLECULAR PHARMACEUTICS, 2009, 6 (01) : 182 - 189
  • [8] Coconut oil raises LDL-cholesterol levels
    Lim G.B.
    [J]. Nature Reviews Cardiology, 2020, 17 (4) : 200 - 200
  • [9] Evolocumab reduces LDL-cholesterol levels in FH
    Robson A.
    [J]. Nature Reviews Cardiology, 2020, 17 (11) : 680 - 680
  • [10] THE INTERACTION OF DIETARY-CHOLESTEROL AND SPECIFIC FATTY-ACIDS IN THE REGULATION OF LDL RECEPTOR ACTIVITY AND PLASMA LDL-CHOLESTEROL CONCENTRATIONS
    DIETSCHY, JM
    WOOLLETT, LA
    SPADY, DK
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 676 : 11 - 26